Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
08/2005
08/10/2005EP1543106A4 Methods and media for controlling sialylation of proteins produced by mammalian cells
08/10/2005EP1404809A4 Improved skin substitutes and uses thereof
08/10/2005EP1379682A4 Cell isolation method and uses thereof
08/10/2005EP1368052B1 Agents, which inhibit apoptosis in cells that are involved in wound healing
08/10/2005EP1336088B1 Step-wise process to recover or eliminate biological substances by flotation from underlayered colloidal medium
08/10/2005EP1210092A4 Calcium-containing structures and methods of making and using the same
08/10/2005EP1133559B1 Human orphan g protein-coupled receptor rup3
08/10/2005EP1123398B1 Molecular pathogenicide mediated plant disease resistance
08/10/2005EP1096941B1 Bone marrow cells as a source of neurons for brain and spinal cord repair
08/10/2005EP0968288B1 A HUMAN 2-19 PROTEIN HOMOLOGUE, z219a
08/10/2005EP0957903B1 Diols of norbornene and norbornane compounds for treating pigmentation disorders, neurodegenerative diseases or proliferative skin disorders
08/10/2005EP0914344B8 ASSAY AND REAGENTS FOR QUANTIFYING hBNP
08/10/2005EP0906443B1 Generating replicating molecules in vivo
08/10/2005EP0901527B1 Regulating metabolism by modifying the level of trehalose-6-phosphate
08/10/2005EP0794797B1 Methods and devices for immunizing a host through administration of naked polynucleotides which encode antigenic peptides
08/10/2005CN1653184A Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)
08/10/2005CN1653183A Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
08/10/2005CN1653182A Recombinant fowlpox virus
08/10/2005CN1653181A Expression of genes in modified vaccinia virus ankara by using the cowpox ATI promoter
08/10/2005CN1653179A Cartilage regeneration using chondrocyte and TGF-beta
08/10/2005CN1653175A RNA detection enzyme
08/10/2005CN1653172A Cotton rat lung cells for virus culture
08/10/2005CN1653084A Mutants of the P4 protein of nontypable haemophilus influenzae with reduced enzymatic activity
08/10/2005CN1653080A Lymphatic and blood endothelial cell genes
08/10/2005CN1652842A 3'- (2z)- 1-(3, 4-dimethylphenyl)-1, 5-dihydro-3-methyl-5-oxo-4h-pyrazol-4-ylidene]hydrazino]-2'-hydroxy- 1, 1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
08/10/2005CN1652839A System and method for treating cardiac arrhythmias with fibroblast cells
08/10/2005CN1652821A Human monoclonal antibodies to prostate specific membrane antigen (PSMA)
08/10/2005CN1652815A Human monoclonal antibodies to influenza M2 protein and methods of making and using same
08/10/2005CN1652681A Barley with altered branching enzyme activity and starch and starch containing products with an increased amylose content
08/10/2005CN1651577A Conditionally replicating viral vectors and their use
08/10/2005CN1651572A Method of external constructing tissue engineering blood vessel
08/10/2005CN1651457A Nucleotide sequences of HIV-1 group (or subgroup) o retroviral antigens
08/10/2005CN1651099A Water soluble binder and its application
08/10/2005CN1650823A Artificial hair mammilla substition structure and its manufacturing method
08/10/2005CN1214244C Immuno assay solid-phase supporter, reagent kit, preparation and use thereof
08/10/2005CN1214115C Fusion protein from antibody cytokine-cytokine inhibitor (selectokine) for use as target-specific prodrug
08/10/2005CN1214110C Cassava vein mosaic virus promoters and uses thereof
08/10/2005CN1214044C ErdB3 antibodies
08/09/2005US6927327 Hybrid corn plants, tissue culture of regenerable cells , protoplasts, male sterile maize plant , produced by cross breeding, genetic engineering transformation, with herbicide resistance, disease resistance, high waxy starch and amylose starch
08/09/2005US6927326 Hybrid maize plant and seed 32A85
08/09/2005US6927317 Modulating ramp activity
08/09/2005US6927061 Capable of differentiating into ovarian surface epithelial and granulosa cells
08/09/2005US6927060 Generation of preferential progenitor cells; obtain cells, separate progenitor cells, progagate and recover preferential progenitor cells
08/09/2005US6927055 Genetic engineered Dna; textile cleaning compounds
08/09/2005US6927054 Peptide for use in the diagnosis, prevention, and treatment of inflammation, cancer, arteriosclerosis and degenerative defects
08/09/2005US6927040 Polpeptide for use in the treatment of granulomatosis, nervous system and skin disorders, bacterial infections and leishmania
08/09/2005US6927035 Antigens used for medical diagnosis of dihydropyrimidine dehydrogenase (DPD) deficiency
08/09/2005US6927026 Orotidine-5′-phosphate decarboxylase-gene, gene construct containing said gene and the utilization thereof
08/09/2005US6926915 Using glycoconjugate polymers to immobilize cell-lectin complexes/non-complexes; separation of clinically important nucleated red blood cells (NRBC) or hematopoietic cells
08/09/2005US6926898 Albumin fusion proteins
08/09/2005US6926893 Multi-stage cascade boosting vaccine
08/09/2005CA2139865C Use of particles of a biocompatible, bioabsorbable calcium salt as active principle in the preparation of a medicament for local treatment of bone demineralizing diseases
08/09/2005CA2019676C Particle-mediated transformation of animal somatic cells
08/06/2005CA2553946A1 Antibodies against clostridium difficile toxins and uses thereof
08/04/2005WO2005071098A1 Method of screening substance improving lipid metabolism
08/04/2005WO2005071092A1 METHOD OF PRODUCING MINUS STRAND RNA VIRUS VECTOR WITH THE USE OF HYBRID PROMOTER CONTAINING CYTOMEGALOVIRUS ENHANCER AND AVIAN β-ACTIN PROMOTER
08/04/2005WO2005071066A1 Methods and compositions for preparing pancreatic insulin secreting cells
08/04/2005WO2005071065A1 Method for studying functional interactions between sensory neurons and keratinocytes or melanocytes
08/04/2005WO2005071064A1 Method of amplifying hematopoietic stem cell and hematopoietic precursor cell
08/04/2005WO2005071063A1 Methods of making and using skin-derived stem cells
08/04/2005WO2005071060A2 Methods and devices for microencapsulation of cells
08/04/2005WO2005071057A1 Magnetic or electric field stimulating device and method for promoting, restraining, or obstructing growth and function of living cell or living tissue using the magnetic or electric field stimulating device
08/04/2005WO2005070967A2 Anti-cancer antibodies with reduced complement fixation
08/04/2005WO2005070964A1 Method of isolating monocytes
08/04/2005WO2005070480A1 Apparatus and methods for enzymatic debridement of skin lesions
08/04/2005WO2005070439A1 Implant comprising a human muscle tissue matrix
08/04/2005WO2005070195A1 Transgenic plant having increased seed weight and utilization thereof
08/04/2005WO2005070136A2 Up-regulation of bone morphogenetic protein (bmp) gene expression in bone cells by electromagnetic signals
08/04/2005WO2005070120A2 Cell culture media
08/04/2005WO2005070090A2 Regulatory t cells suppress autoimmunity
08/04/2005WO2005070066A2 Chlorophyllous totipotent cell cultures
08/04/2005WO2005070011A2 Improved modalities for the treatment of degenerative diseases of the retina
08/04/2005WO2005069970A2 Antibody specificity transfer using minimal essential binding determinants
08/04/2005WO2005069969A2 Mutant sodium channel nav1.7 and methods related thereto
08/04/2005WO2005045001A3 Insulin-producing cells derived from stem cells
08/04/2005WO2005037863A3 Alternative splicing factors polynucleotides, polypeptides and uses thereof
08/04/2005WO2005030298A3 System for injecting liquid drug containing biological material
08/04/2005WO2005026328A3 Cpt resistant cell line
08/04/2005WO2005023994A3 Modified oligonucleotides for telomerase inhibition
08/04/2005WO2005021579A3 Epo mimetic peptides and fusion proteins
08/04/2005WO2004108208A3 Methods and apparatus for conversion of eukaryotic cells by application of electric and magnetic fields
08/04/2005WO2004098533A3 Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
08/04/2005WO2004065408A3 Enhancement of humoral immune responses using a novel myeloid accessory cell
08/04/2005WO2004048408A8 Asb-a transcription repressor proteins and nucleic acids and their application in expansion of stem cells
08/04/2005WO2004025266A3 Method and apparatus for sorting particles
08/04/2005WO2004016726A9 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
08/04/2005US20050172367 Inbred corn line PH8WD
08/04/2005US20050172365 Recombination systems and methods for eliminating nucleic acid sequences from the genome of eukaryotic organisms
08/04/2005US20050172361 Using antisense RNA to inhibit transcription of preferential gene in plant systems
08/04/2005US20050172353 Expression vector for improving heterologous gene expression; herbicide resistant crop plants
08/04/2005US20050172352 Using presence of allelic mutation in protein kinase c gene as diagnostic indication of heart disease
08/04/2005US20050172349 Genetic modification of C57 mice
08/04/2005US20050172347 Using nuclear transformation to generate animal embryo; animal models; uniformity of meat product; animal management
08/04/2005US20050172345 Recombinant cells comprising muscarinic acetylcholine receptor 6 for use in identifying modulators for prevention and treatment of muscle, eating and nervous system disorders
08/04/2005US20050172344 Using hippocampal cells as models for identifying modulators for prevention and/or treatment of nervous system disorders
08/04/2005US20050172343 Astrocyte modulated genes and uses thereof
08/04/2005US20050172342 Production of collagen in the milk of transgenic mammals
08/04/2005US20050171338 Mammalian tribbles signaling pathways and methods and reagents related thereto
08/04/2005US20050171336 Murine ortholog of the human disrupted-in-schizophrenia 1 gene
08/04/2005US20050171041 Identifying drug targets; assaying for expression of candidate ribonucleic acid in RNAi pathway molecule and svRNA
1 ... 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 ... 1827